Delisting Determination, The Nasdaq Stock Market, LLC,
December 29, 2022,  Forward Pharma A/S.
The Nasdaq Stock Market LLC (the Exchange) has determined
to remove from listing the American Depositary Shares of
Forward Pharma A/S (the Company), effective at the opening
of the trading session on January 9, 2023.
Based on review of information provided by the Company,
Exchange Staff determined that the Company no longer qualified
for listing on the Exchange pursuant to Listing Rule 5101.
The Company was notified of the Staff determination on December
16, 2022. The Company did not appeal the Staff determination to
the Hearings Panel. The Staff determination to delist the
Company securities became final on December 27, 2022.